Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
What Is The Biggest Uncertainty For Whitehorse Whfcl Stock Price At 25.17 Down 0.40 20260410 Ramp Uptrend Accelerates On Sector 20260403 1 What Is The Growth Rate Of Cerence Crnc Stock Price At 7.58 Down 3.68 20260409 Is Real Asset Raaqu Stock Expanding Price At 10.80 Down 2.26 20260409 Is Pharming Phar Stock Breaking Out Price At 16.60 Down 0.12 20260406 InMode INMD Stock Direction Change Signals InMode Ltd Ordinary Shares reports 8 EPS surprise TechTarget TTGT Stock PIPE Deal 169 20260416 FEED ENvue Medical Inc slides 125 post Q3 2023 earnings release as no consensus estimate benchmarks are provided What Corebridge CRBD is doing to earn customer loyalty Touches High 20260508 Global Airline and Jet Fuel Market Analysis Amid Iran Conflict Disruptions What is the growth outlook for Ready RC stock Momentum Building 20260420 Smart EM Stock Revenue Analysis Investor Interest 20260420 HOUR Hour Loop shares rise 457 percent following its Q4 2024 earnings release despite unreported core operating metrics Regency REGCP Stock Volume Trend Marginal Gain 20260420 RWT Redwood Trust Q1 earnings miss estimates as revenue drops 41 yearoveryear though shares edge higher How Buenaventura BVN builds value over time Marginal Loss 20260508 Vanguard SmallCap Index Fund ETF VB Top SmallCap ETF Pick to Capture Upside Amid the 2026 Great Rotation When is Callan JMB CJMB next earnings date and what matters most CJMB Q4 Earnings Callan JMB Posts No Formal Guidance Amid Uncertainty How ServiceNow NOW is positioning for the next five years Volatility Increases 20260506 US Wholesale Prices Surge 60 in April Marking Sharpest Annual Gain Since 2022 Motley Fools Shelby McFaddin Offers Cautious View on Consumer Health Ahead of Retail Earnings Season Silexion SLXNW Drops 2258 Key Support at 001 20260515 HIVE HIVE Slides 943 as Selling Pressure Mounts 20260515 Merchants MBINL Q1 2026 Earnings EPS 125 Beats Estimates Nadia Marcinko Faces Potential US Legislative Scrutiny Amid Epstein Legal Proceedings Analyst Report Amgen Inc New Coverage Highlights Biotech Positioning Weibo WB Q3 2025 In Line Whats Next for Investors Anthropic Poised to Reach 109 Billion in Revenue Potentially Marking First Profitable Quarter Jim Cramer Advises Buying Quality Stocks on Pullbacks Amid Market Rotation Kennametal KMT Q1 2026 Results A Closer Look at the Earnings Beat IBF Launches New AI Finance Training Programme for University Students Pfizer Wins Singapore Trademark Dispute with Merck Over Vaccine Brand Jobless Claims Remain Near Historic Lows Signaling Resilient Labor Market SP 500 Notches Gains as Tech Surge Overcomes Energy and Staples Drag Kevin Warsh Poised to Enter Fed Amid Internal Debate Over Interest Rate Cuts Global Stocks Gain as USIran Talks Show Progress Oil Prices Rise NMRA Q1 2026 Earnings NarrowerThanExpected Loss Highlights Cost Discipline in PreRevenue Phase SOHOB Q2 2025 Earnings Preferred Stock Holds Steady as Company Reports Positive EPS Despite Lack of Estimates Research Solutions RSSS Q1 2026 Earnings EPS Misses Estimates Amid Modest Share Decline AMG Q1 2026 Earnings Earnings Beat by Nearly 1 as Stock Dips Slightly Inuvo Q1 2026 Earnings Deep Profit Beat Drives Strong Stock Reaction PIMCO Access Income Fund PAXS Shows Resilience with 107 Gain Tests Key Resistance Able View Global Warrant ABLVW Slides to 002 Amid Thin Trading Inspira Technologies IINN Holds Steady at 038 A Pivot Point for the MedTech Small Cap Allarity Therapeutics ALLR Slides 48 in Session Key Support Levels in Focus Enlight Renewable Energy Ltd ENLT Q1 2026 Earnings EPS of 008 Reported Stock Gains Amid Sparse Disclosure CMCL Q1 2026 Earnings Slight EPS Miss Amid Unreported Revenue Stock Declines FRPT Q1 2026 Earnings WiderthanExpected Loss Despite Positive Stock Reaction CING Q1 2026 Earnings Deep EPS Miss Overshadowed by Positive Stock Movement Incannex Healthcare IXHL Q1 2026 Earnings Deepening Losses as ClinicalStage Biotech Continues PreRevenue Development